Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Thrombocytopenia × eltrombopag × Clear all

Phase

Phase 2 6 Phase 1/2 3 Phase 2/3 2 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Thrombocytopenia 1 Purpura, Thrombocytopenic, Idiopathic 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1

Interventions

eltrombopag 1 Tinzaparin 1 Pharmacokinetics 1 Enoxaparin 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Novartis

Phase 4 Completed

22 enrolled 9 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡